Reliable New Biomarkers of Mitochondrial Oxidative Stress and Neuroinflammation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients: A Pilot Study
Authors:
- Rosa Di LorenzoRLRosa Di Lorenzo
- Chiara ZeccaCZChiara Zecca
- Guglielmina ChimientiGCGuglielmina Chimienti
- Tiziana LatronicoTLTiziana Latronico
- Grazia Maria LiuzziGLGrazia Maria Liuzzi
- Vito PesceVPVito Pesce
- Maria Teresa Dell’abateMDMaria Teresa Dell’abate
- Francesco BorlizziFBFrancesco Borlizzi
- Alessia GiugnoAGAlessia Giugno
- Daniele UrsoDUDaniele Urso
- Giancarlo LogroscinoGiancarlo Logroscino
- Angela Maria Serena LezzaALAngela Maria Serena Lezza
Open Access
- 12 August 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7792
Abstract
Mitochondrial oxidative stress and neuroinflammation are involved in the onset and progression of Alzheimer’s disease (AD). Novel reliable, circulating biomarkers related to these processes were searched in cerebrospinal fluid (CSF) and plasma samples. Paired CSF and plasma samples from 20 subjective memory complaints (SMC) subjects, 20 mild cognitive impairment (MCI) due to AD subjects, and 20 Alzheimer’s dementia (ADd) patients were analyzed. Protein amounts of manganese-containing superoxide dismutase 2 (SOD2), cell-free mitochondrial DNA (cf-mtDNA) level, DNase I, and matrix metalloproteinases 2 and 9 (MMP-2 and MMP-9) activities were determined. As for SOD2, an MCI male-specific significant increase in both biofluids and an ADd male-specific significant decrease in plasma were found. No significant differences were demonstrated in cf-mtDNA level. An ADd-specific significant increase in plasma DNase I and MMP-2 activities was found. A SMC female-specific significant higher value in CSF MMP-9 activity in comparison to male counterparts was demonstrated. The present results suggest a male patient-specific (MCI and ADd) regulation of SOD2 expression in plasma and support an ADd-specific increase in plasma DNase I and MMP-2 activities. Therefore, the potential of SOD2 amount, DNase I, and MMP-2 activities in plasma as new markers of ADd should be explored. The SMC female-specific high activity of MMP-9 might contribute to AD female-sex bias.Keywords
Funding Information
- Regione Puglia and CNR for Tecnopolo per la Medicina di Precisione (CUPB84I18000540002, CUP H99J21017840005)
- C.I.R.E.M.I.C (Research Center of Excellence for Neurodegenerative Diseases and Bari), University of Bari Aldo Moro (CUPB84I18000540002, CUP H99J21017840005)
- BIO-MAD-SEEDS (CUPB84I18000540002, CUP H99J21017840005)
- Fondi di Ateneo FondoQualitàRicerca2024 (University of Bari) (CUPB84I18000540002, CUP H99J21017840005)
- MIUR-FFABR (CUPB84I18000540002, CUP H99J21017840005)
This publication has 86 references indexed in Scilit:
- Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer DiseaseAnnals of Neurology, 2024
- Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer’s diseaseInflammopharmacology, 2023
- The role of mitochondrial dysfunction in Alzheimer's disease pathogenesisAlzheimer's & Dementia, 2022
- 2021 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2021
- Elevated matrix metalloproteinase‐9 levels in neuronal extracellular vesicles in Alzheimer’s diseaseAnnals of Clinical and Translational Neurology, 2020
- Biomarkers in Cerebrospinal Fluid: Analysis of Cell-Free Circulating Mitochondrial DNA by Digital PCR2018
- Manganese superoxide dismutase (SOD2): is there a center in the universe of mitochondrial redox signaling?Journal of Bioenergetics and Biomembranes, 2017
- Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s diseaseBiogerontology, 2015
- Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer diseaseAnnals of Neurology, 2013
- Age- and calorie restriction-related changes in rat brain mitochondrial DNA and TFAM bindingAGE, 2012